Related Experiment Video
Updated: Apr 1, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
Published on: June 13, 2025
Comparison of Taurolock solution with heparin as lock solution of tunneled catheters
Hamad Jeelani1, Manzoor Ahmad Parry2, Amer Said Alameri1
1Department of Nephrology, Sultan Qaboos Hospital, Salalah, Oman.
Insights
Citrate-taurolidine lock solution significantly reduced catheter-related blood stream infections (CRBSI) in hemodialysis patients compared to heparin. This novel solution also demonstrated comparable efficacy in preventing catheter dysfunction.
Area of Science:
- Nephrology
- Infectious Diseases
- Medical Devices
Background:
- Dialysis catheters are associated with catheter-related blood stream infections (CRBSI), increasing hospitalization, morbidity, and mortality.
- Citrate-taurolidine lock solution presents a potential strategy to mitigate CRBSI incidence.
Purpose of the Study:
- To evaluate the efficacy of citrate-taurolidine lock solution in reducing CRBSI.
- To compare the incidence of CRBSI and catheter dysfunction between citrate-taurolidine and heparin lock solutions.
Main Methods:
- Retrospective study involving 89 patients on hemodialysis for at least 6 months using tunneled catheters.
- Comparison of TauroLock-Hep500™ (taurolidine, citrate, heparin) versus heparin lock solution for CRBSI and catheter dysfunction.
Main Results:
- The Taurolock group (42 patients) had 3 CRBSI cases (0.39/1000 catheter days) versus 15 CRBSI cases (1.84/1000 catheter days) in the Heparin group (47 patients).
- Catheter dysfunction rates were similar between the Taurolock and Heparin groups.
- Two patients in the Heparin group required catheter removal, while none in the Taurolock group did.
Conclusions:
- Citrate-taurolidine lock solution significantly reduces CRBSI incidence compared to heparin lock solution.
- TauroLock-Hep500™ demonstrates comparable effectiveness to heparin in preventing catheter dysfunction.
- The use of citrate-taurolidine lock solution may decrease the need for catheter removal due to complications.
Introduction:
The employment of dialysis catheters can result in catheter-related blood stream infections (CRBSI), leads to hospitalization, morbidity, and mortality. Citrate-taurolidine lock solution can lower the occurrence of CRBSI. This study was done to evaluate Citrate-taurolidine lock solution for decreasing CRBSI.
Materials And Methods:
This retrospective study included 89 patients who received hemodialysis for at least 6 months via a tunneled catheter. A comparison was made between patients who were administered TauroLock-Hep500™ (taurolidine, citrate, and heparin) or heparin lock solution for catheter-related infection and catheter dysfunction.
Results:
In this study, 47 patients received heparin lock-solution and 42 patients received Taurolock lock-solution. During a total of 7560 catheter days, the Taurolock group experienced CRBSI in 3 patients. In contrast, the heparin group had 15 patients with CRBSI over a span of 8140 catheter days. This corresponds to an incidence rate of 0.39 episodes of CRBSI per 1000 catheter days in the Taurolock group and 1.84 episodes per 1000 catheter days in the heparin group. Catheter dysfunction rates were similar in the Taurolock group compared to the heparin lock solution. In addition, in the Heparin group, two patients necessitated catheter removal, whereas no patients in the Taurolock group required catheter removal.
Conclusion:
Our study demonstrates a higher incidence of CRBSI in the Heparin group compared to the Taurolock solution and a similar effectiveness of the Taurolock solution in preventing catheter dysfunction over Heparin.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Venous Thrombosis III: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Hemodialysis II: Procedure and Complications

